Skip to main content
Contact Us
Subscribe
E-Edition
94°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
87.27
+0.65 (+0.75%)
Streaming Delayed Price
Updated: 12:54 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 02, 2024
U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
2023's Biggest Losers In The Russell 1,000
January 02, 2024
In this article, we show 35 Russell 1,000 members that fell by at least 30% during the year 2023.
Via
Talk Markets
2 Major Reasons Why Moderna (MRNA) Stock Is Up Today
January 02, 2024
One of the most beaten-down stocks of 2023 in the biotech space, Moderna is seeing a rebound today, with MRNA stock up 15%.
Via
InvestorPlace
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
January 02, 2024
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.
Via
Benzinga
Moderna Inc. (NASDAQ: MRNA) Highlighted for Surprising Price Action
January 02, 2024
Via
Investor Brand Network
This Is What Whales Are Betting On Moderna
December 21, 2023
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
What's Going On With Pfizer Stock?
January 02, 2024
Pfizer, Inc. (NYSE: PFE) shares are trading higher on the first trading day of 2024 after the stock lost more than 40% in 2023.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Via
Benzinga
Tech Stalls As Rising Bond Yields Spook Investors
January 02, 2024
It's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday.
Via
Talk Markets
Moderna Analyst Projects Transformation Into 'Five-Product Commercial Company' By 2026
January 02, 2024
Moderna Inc (NASDAQ: MRNA) is back in focus as it is making advancements in cancer treatment.
Via
Benzinga
Moderna Stock Is Moving Higher: What's Going On?
January 02, 2024
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday following positive analyst coverage from Oppenheimer.
Via
Benzinga
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
December 29, 2023
During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc.
Via
Benzinga
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
December 29, 2023
The pair's collaboration is making waves, and there's more to come.
Via
The Motley Fool
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations.
Via
Benzinga
Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High
December 28, 2023
The market looks set to end 2023 on a high note, but 2024 is less certain, particularly because though, the US does not want further action in the Gulf, it seems, Iran via its proxies is gaming for...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Via
Benzinga
The Winners and Losers: 2023 Stock Market Performance Review
December 27, 2023
The 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't).
Via
InvestorPlace
Why Is RayzeBio (RYZB) Stock Up 100% Today?
December 26, 2023
RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio. Expect more such deals in 2024.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
Via
Benzinga
Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?
December 25, 2023
Some of this year's underperformers could have brighter futures.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
Key Takeaways: Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05...
Via
Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Pfizer's chaotic year wraps up with plunging stock, grim guidance
December 21, 2023
Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.
Via
MarketBeat
Exposures
COVID-19
Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
Via
ACCESSWIRE
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n
Via
Benzinga
Exposures
COVID-19
Long-Term, Organic Revenue Growth Is A Key To Investment Success
December 20, 2023
Revenue growth is probably the easiest of the 4 check boxes to quantify. Anyone can pull up their broker's research pages, or Yahoo Finance, and look at the past 3 or 5 years of revenue.
Via
Talk Markets
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
December 20, 2023
One retail chain may have the clearest path to market-beating upside from here.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
QQQ And QQQM ETFs Top Gainers And Laggards Of 2023
December 20, 2023
This article will look at the top gainers and laggards of the two popular ETFs, which have over $17 billion and $223 billion assets, respectively. The two funds are similar, with the only difference...
Via
Talk Markets
Topics
ETFs
Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now
December 19, 2023
Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.
Via
InvestorPlace
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.